Phibro Animal Health R&D Spending Growth & History (PAHC)
Phibro Animal Health's r&d spending was $24.6M for fiscal 2026.
View full Phibro Animal Health company overviewPhibro Animal Health annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | $24.6M | $825,000 | +3.48% |
| 2025 | 2025-06-30 | $23.7M | −$5.5M | −18.73% |
| 2024 | 2024-06-30 | $29.2M | $4.8M | +19.67% |
| 2023 | 2023-06-30 | $24.4M | $3.6M | +17.10% |
| 2022 | 2022-06-30 | $20.8M | $3.1M | +17.30% |
| 2021 | 2021-06-30 | $17.8M | $4.0M | +29.27% |
| 2020 | 2020-06-30 | $13.7M | $1.6M | +13.60% |
| 2019 | 2019-06-30 | $12.1M | $2.1M | +20.95% |
| 2018 | 2018-06-30 | $10.0M | $556,000 | +5.89% |
| 2017 | 2017-06-30 | $9.4M | −$1.6M | −14.39% |
| 2016 | 2016-06-30 | $11.0M | $1.5M | +15.96% |
| 2015 | 2015-06-30 | $9.5M | $1.3M | +15.82% |
| 2014 | 2014-06-30 | $8.2M | $1.6M | +23.71% |
| 2013 | 2013-06-30 | $6.6M | −$551,000 | −7.66% |
| 2012 | 2012-06-30 | $7.2M | — | — |
Phibro Animal Health r&d spending trends
Over the last five fiscal years, Phibro Animal Health's r&d spending increased from $17.8M to $24.6M, a change of $6.8M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Phibro Animal Health source filings ↗